Promotion of skin epithelial cell migration and wound healing by a 2-benzazepine derivative

European Journal of Pharmacology

Volumn 563, Issue 1-3, 2007, Pages 83-87

  Matsuura, Kenji ^a   Kuratani, Tomohiro ^b   Gondo, Toshikazu ^c   Kamimura, Akio ^a   Inui, Makoto ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY   (Japan)

^c YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

2 Benzazepine; Cell migration; HaCat cell; Re epithelialization; Skin; Wound healing

Indexed keywords

BENZAZEPINE DERIVATIVE; COLLAGEN; N (2,2,2 TRIFLUOROETHYL) 8 METHOXY 4 METHYL 2 BENZAZEPIN 3 ONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELL LINE; CELL MIGRATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN EPITHELIUM; SKIN INJURY; WOUND HEALING;

ANIMALS; BENZAZEPINES; CELL ADHESION; CELL LINE, TRANSFORMED; CELL MOVEMENT; COLLAGEN TYPE I; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; KERATINOCYTES; MICE; MICE, INBRED BALB C; SKIN; TIME FACTORS; WOUND HEALING;

EID: 34247104612     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.02.014     Document Type: Article

References (16)

1. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., and Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106 (1988) 761-771
2. Cavani A., Zambruno G., Marconi A., Manca V., Marchetti M., and Giannetti A. Distinctive integrin expression in the newly forming epidermis during wound healing in humans. J. Invest. Dermatol. 101 (1993) 600-604
3. Clark R.A. The Molecular and Cellular Biology of Wound Repair. second ed (1996), Plenum, New York, NY
4. Coulombe P.A. Wound epithelialization: accelerating the pace of discovery. J. Invest. Dermatol. 121 (2003) 219-230
5. Iorio L.C., Barnett A., Leitz F.H., Houser V.P., and Korduba C.A. SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J. Pharmacol. Exp. Ther. 226 (1983) 462-468
6. Kamimura A., Taguchi Y., Omata Y., and Hagihara M. Convenient synthesis of 2-benzazepines via radical cyclization. J. Org. Chem. 68 (2003) 4996-4998
7. Keenan R.M., Miller W.H., Kwon C., Ali F.E., Callahan J.F., Calvo R.R., Hwang S.M., Kopple K.D., Peishoff C.E., Samanen J.M., Wong A.S., Yuan C.K., and Huffman W.F. Discovery of potent nonpeptide vitronectin receptor (alpha v beta 3) antagonists. J. Med. Chem. 40 (1997) 2289-2292
8. Lark M.W., Stroup G.B., Hwang S.M., James I.E., Rieman D.J., Drake F.H., Bradbeer J.N., Mathur A., Erhard K.F., Newlander K.A., Ross S.T., Salyers K.L., Smith B.R., Miller W.H., Huffman W.F., and Gowen M. Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis. J. Pharmacol. Exp. Ther. 291 (1999) 612-617
9. Lark M.W., Stroup G.B., Dodds R.A., Kapadia R., Hoffman S.J., Hwang S.M., James I.E., Lechowska B., Liang X., Rieman D.J., Salyers K.L., Ward K., Smith B.R., Miller W.H., Huffman W.F., and Gowen M. Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized rat. J. Bone Miner. Res. 16 (2001) 319-327
10. Martin P. Wound healing-aiming for perfect skin regeneration. Science 276 (1997) 75-81
11. Miller W.H., Bondinell W.E., Cousins R.D., Erhard K.F., Jakas D.R., Keenan R.M., Ku T.W., Newlander K.A., Ross S.T., Haltiwanger R.C., Bradbeer J., Drake F.H., Gowen M., Hoffman S.J., Hwang S.M., James I.E., Lark M.W., Lechowska B., Rieman D.J., Stroup G.B., Vasko-Moser J.A., Zembryki D.L., Azzarano L.M., Adams P.C., and Huffman W.F. Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model. Bioorg. Med. Chem. Lett. 9 (1999) 1807-1812
12. Miller W.H., Alberts D.P., Bhatnagar P.K., Bondinell W.E., Callahan J.F., Calvo R.R., Cousins R.D., Erhard K.F., Heerding D.A., Keenan R.M., Kwon C., Manley P.J., Newlander K.A., Ross S.T., Samanen J.M., Uzinskas I.N., Venslavsky J.W., Yuan C.C., Haltiwanger R.C., Gowen M., Hwang S.M., James I.E., Lark M.W., Rieman D.J., Stroup G.B., Azzarano L.M., Salyers K.L., Smith B.R., Ward K.W., Johanson K.O., and Huffman W.F. Discovery of orally active nonpeptide vitronectin receptor antagonists based on a 2-benzazepine Gly-Asp mimetic. J. Med. Chem. 43 (2000) 22-26
13. Nguyen B.P., Ryan M.C., Gil S.G., and Carter W.G. Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr. Opin. Cell Biol. 12 (2000) 554-562
14. Santoro M.M., and Gaudino G. Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp. Cell Res. 304 (2005) 274-286
15. Werner S., and Grose R. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83 (2003) 835-870
16. Xia W., Spector S., Hardy L., Zhao S., Saluk A., Alemane L., and Spector N.L. Tumor selective G2/M cell cycle arrest and apoptosis of epithelial and hematological malignancies by BBL22, a benzazepine. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 7494-7499